Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050
Opinion | 18 September 2025
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
ONCOLife | 27 May 2025
Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'
ONCOLife | 10 May 2025
AI in Life Sciences: Trends and Predictions for 2025 - By Doron Sitbon
AI | 21 February 2025
The Internet of Medical Things needs a new security model to fulfil its potential
Digital Health | 13 January 2025
Healthy Planet: How The Pharmaceutical Industry Can Reduce Its Emissions
Opinion | 9 August 2024
Can Artificial Intelligence Help Bridge the Gap in Healthcare Tech Skills?
Opinion | 10 May 2024
AI and VR – two little acronyms that will change the healthcare world this year
Opinion | 26 January 2024
Deloitte's Survey Uncovers Optimism and Concerns in Generative AI Adoption
Opinion | 15 January 2024
Beyond SEP-1: Evolving Strategies in Sepsis Care and CMS Reimbursement Policies
Opinion | 13 November 2023
How a service design approach can make digital hospitals a reality?
Opinion | 8 November 2023
Subscribe for the latest news and events
Most Popular
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma